London Stock Exchange Group

BREXIT-PROOF, COVID-PROOF, DEAR LSEG (REDUCE, 8% DOWNSIDE)

20/05/20 -"We have long had a Buy recommendation (or Add at worst) on the London Stock Exchange Group (Reduce, UK) as evidenced in the graph below. As we regularly mentioned in earlier Teasers on the LSEG, the ..."

PDF page sample
Pages
52
Language
English
Published on
20/05/20
Download
You may also be interested by these reports :
24/07/26
Deutsche Börse’s Q2-26 beat consensus (pretax +3%), with net revenue €1.62bn (+7%; +9% ex-treasury) and EBITDA €979m (+10%). Trading normalized as ...
24/07/26
H1-26 confirmed Leonteq’s profitability rebound, beating pre-tax consensus with a +10% fee income growth and a healthier revenue mix, validating that ...
23/07/26
Eurazeo reported another good quarter on the asset management side with good fundraising, AUM growth, and an increase in management fees. The ...
22/07/26
Yes indeed! Bolloré controls Vivendi

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO